Oramed Pharmaceuticals

Company snapshot

Oramed Pharmaceuticals Inc. ([Hebrew](en.wikipedia.org/wiki/Hebrew_language): אורמד), is a publicly traded company engaged in the development of [oral drug delivery](en.wikipedia.org/wiki/Oral_drug) systems – most notably an oral insulin capsule for treating [type 2 diabetes](en.wikipedia.org/wiki/Type_2_diabetes). The company was founded in 2006 and is headquartered in [Jerusalem](en.wikipedia.or

• 14 active pipeline program(s) linked via ClinicalTrials.gov.
• 10 US patent(s) indexed to this assignee profile.
• 14 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Oramed Pharmaceuticals. Not investment advice.

• Peer + 0 momentum

  Sanofi Pasteur MSD

  TA overlap score 36.6

• Peer + 0 momentum

  Hong Kong Baptist

  TA overlap score 23.6

• Peer + 0 momentum

  vTv Therapeutics

  TA overlap score 22.8

Recent activity

Latest pipeline, patent, and corporate events for Oramed Pharmaceuticals.

1. Jun 8, 2026 Clinical update

   Oral Insulin — Phase 2

2. Jun 8, 2026 Clinical update

   ORMD-0801 (qd) — Phase 3

3. Jun 5, 2026 Clinical update

   ORMD-0801 Treatment A — Phase 2

4. Jun 5, 2026 Clinical update

   ORMD-0801 QD — Phase 2

5. Jun 5, 2026 Clinical update

   ORMD-0801 (Insulin) capsule 8 mg BD — Phase 2

View all clinical trial activity →

• What is Oramed Pharmaceuticals?

  Oramed Pharmaceuticals is a pharma organization headquartered in Jerusalem, USA. It trades on NYSE under ticker ORMP. Primary therapeutic focus areas include T2DM (Type 2 Diabetes Mellitus), Type 2 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 2, Non-Alcoholic Steat

• Is Oramed Pharmaceuticals publicly traded?

  Yes. Oramed Pharmaceuticals is listed with ticker ORMP on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Oramed Pharmaceuticals develop or market?

  We link 8 drug profile(s) where Oramed Pharmaceuticals is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/oramed-pharmaceuticals-inc#company-drugs.

• What are the latest developments for Oramed Pharmaceuticals?

  In the last 12 months our linked public records show 14 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Oramed Pharmaceuticals focus on?

  Oramed Pharmaceuticals focuses on T2DM (Type 2 Diabetes Mellitus), Type 2 Diabetes Mellitus, Type 1 Diabetes based on our analysis of their pipeline programs and drug development activities.